K31.A21
Gastric intestinal metaplasia with low grade dysplasia
Clinical Classification Guidelines
Medical Intelligence & Overview
Gastric intestinal metaplasia with low grade dysplasia is a condition characterized by changes in the stomach lining that may be precancerous. It involves the transformation of normal stomach cells into intestinal-type cells, combined with early signs of abnormal cell growth. Recognizing and understanding this condition is important for monitoring and managing potential risks related to gastric health.
Causes & Symptoms
Clinical Causes: Helicobacter pylori infection Chronic gastritis (long-term inflammation of the stomach lining) Dietary factors, including high intake of smoked or salted foods Genetic predisposition Environmental influences such as smoking and alcohol consumption Autoimmune disorders affecting the stomach
Key Symptoms: Often asymptomatic in initial stages Persistent indigestion or discomfort in the stomach area Bloating and feeling full quickly after eating Nausea or occasional vomiting Unintentional weight loss in some cases Possible anemia due to blood loss or malabsorption
Diagnostic & Treatment
Diagnosis Path: - Additional testing such as Helicobacter pylori testing may be recommended
Treatment Protocols: - In some cases, surgical intervention may be considered if significant dysplasia progresses
Clinical Advice & FAQs
Billing Guidance
Is K31.A21 a billable ICD-10 code?
Yes, K31.A21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report K31.A21?
Clinical documentation must specify the nature of Gastric intestinal metaplasia with low grade dysplasia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
